ETC-1002 Lowers LDL-Cholesterol and Beneficially Modulates Other Cardio-Metabolic Risk Factors in Hypercholesterolemic Subjects†

Noah Rosenberg, MD, Diane MacDougall, MSc, Jeffrey Hanselman, MS, Mark Milad, PharmD, Scott McBride, MA, Lorenzo A. DiCarlo, MD, Roger Newton, PhD, Christie Ballantyne, MD, Michael H. Davidson, MD, Randall Severance, MD, James McKenney, PharmD, James VanderLugt, MD, Harold Bays, MD, John Rubino, MD, Stephen Wayne Halpern, MD, Linda Gaudiani, MD, Michael Koren, MD, Jennifer Robinson, MD, MPH, (Plymouth, Michigan)